1/69
Flashcards covering vocabulary and core concepts from the lecture on migraines, insomnia, and seizures, including medications, diagnosis, and clinical characteristics.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Vascular emergency headache
Headache associated with vascular problems such as hypertensive crisis, stroke, or intracranial bleeding.
Ergotamine
Migraine medication that causes prolonged cranial vasoconstriction and inhibits neurogenic inflammation.
Status epilepticus treatment
Benzodiazepines followed by IV antiepileptic drugs.
Headache
Most common neurologic symptom; may be vascular, muscle-contraction, or combination and ranges from mild to severe.
Red flag headache
A headache that may indicate a serious underlying condition such as hemorrhage, infection, tumor, or increased intracranial pressure.
Thunderclap headache
Sudden severe headache described as the "worst headache of my life"; classic sign of subarachnoid hemorrhage.
Space-occupying headache
Caused by mass effect or increased intracranial pressure such as brain tumor, brain abscess, or swelling.
Infectious headache
Headache associated with infection such as meningitis or encephalitis and often accompanied by fever and stiff neck.
Tension headache
Band-like pressure headache caused by muscle tension or stress and usually mild to moderate in severity.
Migraine headache
Moderate to severe unilateral throbbing headache associated with nausea, vomiting, photophobia, and phonophobia.
Cluster headache
Severe unilateral headache around the eye accompanied by autonomic symptoms such as tearing, nasal congestion, ptosis, or miosis.
Migraine aura
Neurologic symptoms such as visual flashes, smells, or sensory changes that occur shortly before a migraine.
Migraine triggers
Factors that can precipitate migraines including stress, hormonal changes, flashing lights, strong odors, certain foods, and sleep disturbances.
Migraine abortive therapy
Medication taken at the onset of a migraine attack to stop or reduce symptoms.
Migraine preventive therapy
Medication taken regularly to reduce the frequency and severity of migraines.
NSAIDs (migraine treatment)
Drugs that inhibit cyclooxygenase (COX) enzymes and decrease prostaglandin production to reduce inflammation and pain.
Acetaminophen
Mild analgesic that works through central pain inhibition and is commonly used for mild migraine treatment.
Caffeine (migraine therapy)
Enhances analgesic absorption and causes cerebral vasoconstriction to improve headache relief.
Medication-overuse headache
Rebound headaches caused by frequent use of analgesics or migraine medications.
Triptans
Class of drugs that are selective serotonin (5-HT1B/1D) receptor agonists causing cranial vasoconstriction to treat acute migraine.
Sumatriptan
Prototype triptan used for acute migraine attacks.
Triptan contraindications
Conditions such as coronary artery disease, stroke history, uncontrolled hypertension, or peripheral vascular disease.
Serotonin syndrome
Potentially life-threatening condition caused by excessive serotonin activity; may occur when triptans are combined with SSRIs or SNRIs.
Ergotamine precautions
Contraindicated in cardiovascular disease, pregnancy, and uncontrolled hypertension due to ischemia risk.
Insomnia
Inability to fall asleep, stay asleep, or feel refreshed after sleep.
Acute insomnia
Short-term insomnia lasting days to weeks.
Chronic insomnia
Insomnia lasting longer than one month.
Non-restorative sleep
Sleep that does not provide adequate recovery due to CNS hyperarousal and disrupted sleep cycles.
Sleep hygiene
Behavioral practices that improve sleep such as avoiding caffeine before bed, maintaining routine sleep times, and reducing nighttime stimulation.
Sedative-hypnotics
Drugs that depress the central nervous system to promote sleep.
Tolerance
Reduced drug effectiveness over time requiring higher doses for the same effect.
Dependence
Physiologic or psychological need for a drug that may cause withdrawal symptoms if discontinued.
GABA
Gamma-aminobutyric acid, the primary inhibitory neurotransmitter in the central nervous system.
Benzodiazepines
Drugs that enhance GABA activity at GABA-A receptors to produce sedation and decrease neuronal excitability.
Temazepam
A benzodiazepine commonly used short term for insomnia.
Benzodiazepine mechanism
Increases GABA activity causing chloride channel opening and neuronal hyperpolarization.
Hyperpolarization
Increase in negative charge inside a neuron that reduces the likelihood of neuronal firing.
Flumazenil
Benzodiazepine antidote used to reverse benzodiazepine toxicity.
Benzodiazepine black box warning
Combining benzodiazepines with opioids or alcohol can cause severe respiratory depression and death.
Zolpidem
Non-benzodiazepine sedative-hypnotic used for short-term treatment of insomnia.
Zolpidem serious risks
Complex sleep behaviors such as sleep-walking or sleep-driving and worsening depression.
Ramelteon
Melatonin receptor agonist used to regulate circadian rhythm and treat sleep initiation insomnia.
Melatonin receptor agonist mechanism
Stimulates MT1 and MT2 receptors to regulate circadian rhythm and promote sleep.
Seizure
Transient abnormal electrical activity in the brain causing changes in behavior, movement, or consciousness.
Epilepsy
Chronic neurologic disorder characterized by recurrent unprovoked seizures.
Prodromal phase
Early warning phase occurring hours to days before a seizure with mood or behavioral changes.
Aura
Brief sensory warning before a seizure such as visual disturbances or unusual smells.
Ictal phase
Active seizure period characterized by abnormal motor or neurologic activity.
Postictal phase
Recovery phase after a seizure marked by confusion, fatigue, and headache.
Focal seizure
Seizure originating in one area of the brain.
Tonic-clonic seizure
Generalized seizure with loss of consciousness and rhythmic muscle contractions.
Absence seizure
Brief seizure characterized by sudden staring and brief loss of awareness without postictal confusion.
Atonic seizure
Sudden loss of muscle tone causing a drop attack.
Status epilepticus
Seizure lasting longer than 5 minutes or repeated seizures without recovery between episodes.
EEG (electroencephalogram)
Test that records electrical activity of the brain using scalp electrodes to support seizure diagnosis.
Antiepileptic drugs (AEDs)
Medications used to reduce neuronal hyperexcitability and control seizures.
AED withdrawal risk
Abrupt discontinuation can trigger rebound seizures or status epilepticus.
Traditional AEDs
Older antiepileptic drugs with more side effects and drug interactions (phenytoin, carbamazepine, valproic acid).
Newer AEDs
Newer antiepileptic drugs with fewer side effects and interactions (levetiracetam, gabapentin).
Phenytoin
Antiepileptic drug that blocks sodium channels to stabilize neuronal membranes.
Phenytoin toxicity sign
Ataxia is a classic early sign of toxicity.
Phenytoin therapeutic level
10−20mcg/mL
Purple glove syndrome
Severe tissue injury caused by IV phenytoin infiltration.
Carbamazepine
Antiepileptic drug also used for trigeminal neuralgia and bipolar disorder.
Carbamazepine monitoring
Monitor CBC due to risk of leukopenia, anemia, and thrombocytopenia.
Valproic acid
Antiepileptic drug that increases GABA and decreases neuronal excitability.
Valproic acid major risk
Hepatotoxicity requiring monitoring of liver function tests.
Levetiracetam
Newer AED with fewer drug interactions and primarily renal elimination.
Gabapentin
AED that modulates calcium channels and reduces excitatory neurotransmitter release.
AED patient teaching
Avoid alcohol, take medications consistently, and never stop abruptly without tapering.